Quercus acuta Thunb. Suppresses LPS-Induced Neuroinflammation in BV2 Microglial Cells via Regulating MAPK/NF-κB and

Jae Kwang Kim1, Hye Jin Yang1, Younghoon Go1

  • 1Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Korea.

Insights

Quercus acuta extract reduces neuroinflammation by inhibiting key inflammatory pathways like NF-κB and MAPK, while activating protective Nrf2/HO-1 signaling. This suggests potential for preventing neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Microglial activation drives neuroinflammation, a key factor in neurodegenerative diseases.
  • Targeting microglial inflammatory responses offers a therapeutic strategy for neuroprotection.

Purpose of the Study:

  • To investigate the anti-neuroinflammatory effects of Quercus acuta extract (QAE).
  • To elucidate the underlying molecular mechanisms of QAE in lipopolysaccharide (LPS)-stimulated BV2 microglial cells.

Main Methods:

  • BV2 microglial cells were stimulated with LPS.
  • Cells were pretreated with QAE, and effects on nitric oxide, proinflammatory cytokines, inflammatory enzymes, and signaling pathways (NF-κB, MAPK, Nrf2/HO-1) were analyzed.

Main Results:

  • QAE inhibited nitric oxide and proinflammatory cytokine production.
  • QAE suppressed the activation of NF-κB and MAPK signaling pathways.
  • QAE activated Nrf2/HO-1 signaling, reducing oxidative stress.

Conclusions:

  • Quercus acuta extract exhibits significant anti-neuroinflammatory properties.
  • QAE exerts its effects by modulating NF-κB, MAPK, and Nrf2/HO-1 pathways.
  • Phytochemicals like catechin and taxifolin contribute to QAE's anti-inflammatory action.